Académique Documents
Professionnel Documents
Culture Documents
w w w. c e n t a u r p h a r m a . c o m w w w. c e n t a u r p h a r m a . c o m
Corporate
Business Spread (Sales) Geographical Spread (Sales)
31%
22%
69%
78%
API Formulations
w w w. c e n t a u r p h a r m a . c o m
Corporate
Established 1978 Rank 51 - IMS-ORG (India) Rank 45 - Rx audit- CMARC
Exports to 95 countries
Competencies across the pharmaceutical value chain
w w w. c e n t a u r p h a r m a . c o m
API 110
CRO 60
w w w. c e n t a u r p h a r m a . c o m
w w w. c e n t a u r p h a r m a . c o m
3577
Ointments
Tonnes
1280
w w w. c e n t a u r p h a r m a . c o m
API, Ambernath
India's largest Psychotropic API player, introduced 28 API in India USFDA / AFSSAPS approved
w w w. c e n t a u r p h a r m a . c o m
Formulations Marketing
Exports to Asia, Americas, Africa India- 50 million+ Rx annually Brand leader in 6 therapy segments 1145 Sales force, 10,000 Drs and 10,000 pharmacies daily
1 Rx / Second
33Mn Rx / Year
w w w. c e n t a u r p h a r m a . c o m
Samruddhi Shasvatam
Praggya
95 71 28
43 44
11
Sankalp Centaur
79 932
19 213
98 1145
2 100
w w w. c e n t a u r p h a r m a . c o m
Contract Research
Fully integrated set-up- BA / BE / Clinical trials (Phase II/III) International standard CRO -10,000 sq.ft. 42 bed CPU, fully-equipped ICU
w w w. c e n t a u r p h a r m a . c o m
Strategic Alliances
Strategy- Harness CRO, API & marketing proficiencies Partner Country Japan Molecule Sorivudine Indication Topical antiviral for Herpes Zoster Glaucoma Status Development & distribution rights for India++ Centaur to conduct PII/PIII trials, launch 2014 Launched 2011
Timolol LA Japan
Bromfenac
DPOCL (Diperoxochloric Acid)
NSAID
Diabetic Foot Ulcer solution
Launch 2012
NCE, development rights Phase II successful Phase III WIP Launch by 2013
Germany
w w w. c e n t a u r p h a r m a . c o m
Strategic Alliances
API EU Synthon, EGIS, Stada, NTIM, Mylan, Pfizer, Mayoli Spindler Contract Manufacturing GSK, Blue Fish NRIM, Zanza, Wockhardt, Aurobindo, Bluemont STI, Ingenus, IPG Contract Research Wessex, Kirka Orion,HennigArzneimittel,
Americas
Sepracor, Pharmascience, Actavis, Lab Teuto, Ratiopharm, Apotex, Caraco, Mylan, Sandoz Allergan, Euro Pharma, Delta Pharma, Al-andalous, Cooper Moroc Wyeth, Sun Pharma, Intas, Zydus, Alcon, Nicholas
Sanofi-Aventis, Novartis
Inventia
Rodan , IndusPharma, Sami Pharma, Wilshire Generic Partners, Labs, ACME, Healthcare, General, Delta, Thinz Sandoz We Impart Health to Life
w w w. c e n t a u r p h a r m a . c o m
Why Centaur
BA/BE studies Clinical trials R&D Contract Research API
Contract Manufacturing Pan India 1145 Sales Force 50,000,000 Rx 250,000 Drs and pharmacies / month
Formulations
w w w. c e n t a u r p h a r m a . c o m
Future
Formulations Contract Research Contract Manufacturing
API
2011
w w w. c e n t a u r p h a r m a . c o m
2016
We Impart Health to Life
Contact
Centaur Pharmaceuticals Pvt. Ltd.
Centaur House, Vakola, Santacruz (E), Mumbai-400 055. INDIA Tel. : +91-22-6649 9100 Fax : +91-22-6649 9108 / 112 Website: www.centaurpharma.com Email: centaur@centaurlab.com
Business
API & Formulations
E mail / Website
export@centaurchem.com
Website
www.centaurchem.com www.centaurpharma.com
centaur_pune@centaur.co.in lifesan@lifesan.in
www.centaurpharma.com www.lifesan.in
w w w. c e n t a u r p h a r m a . c o m